Fight Retinal Blindness! Registry Data: Ranibizumab and aflibercept safe for treating DME - Ophthalmology Times


5/29/2022 12:00:00 AM2 years 11 months ago
by Lynda Charters

A team of investigators has found that a comparison of ranibizumab and aflibercept showed both drugs safe and effective for treating diabetic macular edema.

A team of investigators has found that a comparison of ranibizumab (Lucentis, Genentech) and aflibercept (Eylea, Regeneron Pharmaceuticals) showed both drugs safe and effective for treating diabetic … [+3104 chars]

full article...